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The formation of protein fibrils is a consistent feature in the
pathogenesis of several neurodegenerative diseases. The use
of nanoparticles as theranostic agents to inhibit fibril formation
has been suggested as a potential treatment for these so-
called amyloid diseases. Protein fibrillation is defined as the
process by which partially or fully unfolded proteins form
beta-strand-stacked structures leading to formation of large
insoluble linear aggregates or amyloid.[1] Many proteins and
peptides form amyloid-type structures, including amyloid beta
(Ab) peptide,[2] prion protein,[3] a-synuclein,[4] polyglutamine,[5]
glucagon,[6] and b2-microglobulin.
[7]
Amyloid beta deposits are found between neurons in pa-
tients with Alzheimer’s disease, and have therefore received
much attention. Ab is also widely used as a model protein to
investigate the effect of nanomaterials (NMs) on the fibrillo-
genesis of proteins.[8] Ab, which has a molecular weight of
~4 kDa, is an amphipathic polypeptide prone to self-associa-
tion and fibril formation.[9] Monomeric Ab, is an unstructured
peptide that is soluble under physiological conditions,[10] how-
ever, the fibrillar form has a characteristic cross-b structure
with stacking of b strands perpendicular to the long axis of the
fiber.[10] While the fibrillation process can be affected by the
presence of NMs, the acceleratory or inhibitory effect is highly
dependent on the physicochemical properties of the NM and
on the protein characteristics.[11]
It is now well recognized that the surfaces of NMs become
covered with a condensed layer of biomolecules, called a pro-
tein corona, upon exposure to biological media.[12] The exact
composition of proteins in the corona is dependent on the
specific surface properties of the NM, as only proteins with
a strong affinity towards the NM surface will remain in the
corona, eventually displacing proteins with lower affinity. The
NM protein corona has been shown to last sufficiently long
that the pristine surface of the NM is unlikely to ever be ex-
posed in the biological milieu. NMs of various surface chemis-
tries and sizes have been shown to both accelerate and inhibit
Ab fibrillation in solution.[8,11a, 13] Direct interaction of the Ab
peptide with the surface of the NM occurred in both cases.
Where the NM promoted fibril formation, nucleation was accel-
erated on the surface, increasing the rate at which fibrils
formed. When the NM inhibited formation, small oligomeric
forms of Ab were present on the surface; this reduced the so-
lution concentration and thus the probability for formation of
a critical nucleus, and therefore the rate of fibril formation was
slowed. Although these are important observations, in order to
understand the fate of Ab exposed to NMs in a biological con-
text, we must assess the interactions with NMs in the state in
which they encounter Ab : we know that this will not be as
a pristine NM, but as a NM bearing a protein corona. Thus an
important step forward in developing our understanding of
Ab–NM interactions in more biologically relevant conditions is
to consider the case where the NM surface is already precov-
ered with proteins and thus potentially less accessible to the
Ab, that is, to study the effect of protein-corona-coated NMs
on Ab fibrillation.
Here we investigate the effects of protein-coated NMs on
the fibrillation of Ab, and discuss how the protein corona shell
has an inhibitory effect on Ab fibrillation, regardless of the NM
physicochemical properties (e.g. , composition, size, shape
(aspect ratio), and surface properties). Several different NMs
(silica (100 and 200 nm), polystyrene with carboxyl surface
modification (100 nm), and multi-walled carbon nanotubes
(CNT; diameter: 10–40 nm and length: 0.1–10 mm; see Fig-
ure S1 and Table S1 in the Supporting Information)) were em-
ployed in this study and their effects on the Ab fibrillation pro-
cess were probed in the absence and presence of a protein
corona, as well as well as under conditions under which the
protein corona was denatured.
The protein-coated NMs were prepared by incubating the
NMs with plasma proteins at protein concentrations of 10% (in
vitro simulated medium) and 100% (in vivo simulated
medium, see the Supporting Information for details) for 1 h to
allow proteins to condense onto the NM surface. This was fol-
lowed by several washing steps to remove the loosely at-
tached proteins from the surface of the NMs and leave only
the strongly bound “hard corona” proteins attached to the
NMs. In experiments to measure fibrillation, the NMs (bare and
protein-coated; NM concentrations were fixed at 100 mgmL1)
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were mixed with Ab (5, 20 or 40 mm depending on the experi-
ment), and Ab fibril formation was measured using the Thiofla-
vin T (ThT) assay. ThT binds primarily to protein fibrils and not
to oligomeric forms which precede fibril formation. A typical
ThT assay is therefore characterized by a lag time, where nucle-
ation and oligomerization of Ab occur, followed by the appear-
ance of protein fibrils (observed as an increase in ThT fluores-
cence). Figure 1 shows the results of ThT assays for Ab in the
presence of NMs of varying composition, size aspect ratio and
surface charge, with and without protein coronas (formed at
10 or 100% plasma) and Figure S2 shows the reproducibility of
the data.
These measurements show that all “bare” NMs used for the
study accelerate the rate of Ab fibril formation, in agreement
with literature. However when the NMs were precoated with
a plasma protein corona it resulted in a considerable increase
in the lag times for the fibrillation process, compared with that
in the presence of the pristine NMs. For 100 nm silica NMs,
fibrillation in the presence of the corona-coated NMs actually
occurred more slowly than for free Ab. The extent to which
the lag time for Ab fibrillation increased depended on the
NM–protein corona composition. Particles incubated in 100%
plasma showed greater inhibitory effects than particles coated
in 10% plasma, for all NMs used in this study (see Figure 1B).
NMs bearing a protein corona slowed the fibrillation of Ab, re-
gardless of size, surface chemistry, charge or aspect ratio when
compared with the same pristine (bare) NM. It is known that
the composition and thickness of the protein corona is depen-
dent on the ratio of the NM surface area to protein concentra-
tion, and to a lesser extent on the incubation time of the NMs
and plasma proteins.[14] In order to assess the effect of pro-
tein–NM interaction time on the Ab fibrillation process,
100 nm silica nanoparticles were used to probe the fibrillation
process in a time-resolved manner (1 and 6 h). The lag time for
Ab fibrillation was observed to increase with both increasing
plasma protein concentration and increasing incubation time.
Although there was a modest increase in the lag time with
NMs incubated in plasma (at both concentrations) for longer
times, a much greater increase in lag time was achieved when
the NM was incubated at the higher plasma concentration
(Figure 2).
Figure 1. Kinetics of Ab fibrillation in the absence and presence of NMs with
and without a protein corona. A) Fibrillation kinetics of Ab (5 mm) after incu-
bation with pristine and protein-corona-coated NMs. B) Calculated lag times
for Ab (5 mm) after incubation with pristine and protein-corona-coated NMs.
Figure 2. Effect of NM-plasma incubation time on the kinetics of Ab fibrilla-
tion (Ab concentration: 20 mm) in the presence of NMs. A) Time-dependent
ThT fluorescence was used to monitor Ab fibrillation in the absence and
presence of protein-coated NMs, in a time resolved manner (e.g. , 6 h-100%
is the 100 nm silica NM preincubated with 100% plasma for a period of 6 h).
B) calculated lag times from (A).
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Differential centrifugal sedimentation (DCS) has been previ-
ously used to characterize nanoparticle–corona complexes.[14]
To ensure that our nanoparticles were coated with a corona
consistent with what has been observed for other nanoparticle
systems, DCS experiments were conducted on silica particles
with and without a corona in the presence and absence of Ab.
The DCS results are consistent with those obtained for other
NM corona systems (Figures S4 and S5). These measurements
show that the main peaks of the bare 100 nm and 200 nm
silica NMs were shifted slightly to lower sizes, after incubation
in plasma, removal of excess plasma protein and resuspension
in buffer. The decrease in observed (apparent) size is due to
the change in density of the NM–corona complex relative to
the bare NM, since the actual size of the particles increases, as
confirmed by our previous reports.[14,15] This apparent size de-
crease is consistent with results obtained previously.[14] After
addition of Ab monomers, the NM corona peak is shifted to
slightly lower sizes again, consistent with the addition of Ab to
the corona and a further decrease in the overall particle–
corona density.
Surface curvature was not observed to play a key role in the
NM-induced Ab fibrillation process: measuring the fibrillation
rate of 100 and 200 nm silica NMs where the surface area was
fixed, no change of fibrillation rate was observed. The results
are shown in Figure S3. In this case, when the NM surface area
exposed to Ab is fixed, there was no significant particle-size
effect at either Ab concentration (20 or 40 mm Ab).
In order to confirm the ThT assay data, transmission electron
microscopy (TEM) of several samples was conducted. TEM
images (Figures 3A–D and S6) demonstrate that Ab oligomers
and protofibrils were formed both in the bulk solution and at
the surface of protein-coated NMs. Interestingly, mature fibrils
were not observed either on the corona-coated NM surface or
free in solution, even after several hours of incubation (Fig-
ure 3C and D).
We (and others) have shown that pristine MNs can acceler-
ate the rate of fibril formation of Ab in solution.[16,17] We have
shown here, however, that the protein corona, which is known
to coat NMs in a biological environment, decreases the rate of
fibril formation (measured by ThT assay and TEM). This hap-
pens for every type of NM we have tested. In the presence of
silica NMs (100 and 200 nm), fibrillation occurs more slowly
than for Ab alone and is independent of particle size. DCS ex-
periments indicate that Ab binds to the NM corona, and fea-
tures consistent with Ab oligomers have been observed on the
surface of corona-coated silica NMs by TEM (Figure S6). Nota-
bly, the TEM images also show an absence of fibrillar structures
either at the corona surface or in bulk solution. Taken together,
these results suggest that nucleation of Ab can and does occur
on the NM surface even in the presence of a protein corona,
but that growth of fibrils terminates at some point and does
not proceed to the formation of mature fibrils. If indeed this is
the case, the corona-coated particles, may act as a “sink” for
Ab, reducing the bulk concentration of the peptide and de-
creasing the likelihood of nucleation in the bulk while also pre-
venting growth of fibrils on the corona surface, perhaps due to
steric repulsion from the corona-coated particles, or more com-
plex protein–protein interactions between the Ab peptide and
other proteins in the corona. To test this hypothesis, corona-
coated silica NMs were incubated with Ab monomer (5 mm) for
several hours to allow the peptide to bind to the NM corona.
The particles were then recovered by gentle centrifugation
and washed to remove unbound peptide. These corona-
coated NMs containing preseeded Ab oligomers/protofibrils
were then mixed with fresh Ab monomer (5 mm), and TEM
images were taken after 6 h (Figure 4). We see here that there
is significant aggregation of the corona-coated silica NMs,
probably through Ab assemblies. Interestingly, there is still an
absence of mature Ab fibrils in all samples with only short fi-
brillar structures observed with 10% plasma-coated silica NMs
and even smaller assemblies present with the 100% plasma-
coated silica NMs.
Figure 3. TEM images of A) Ab fibrils, B) bare 100 nm silica NMs (1 mgmL1),
C) and D) 100 nm corona-coated silica NMs (plasma concentrations of 10%
and 100%, respectively) incubated with Ab. Images were taken after 6 h of
incubation of the various NMs with Ab. Scale bars: 500 nm.
Figure 4. TEM images of 100 nm silica NMs incubated in A) 10% and
B) 100% plasma containing 5 mm Ab where the NMs were collected by cen-
trifugation and subsequently incubated with fresh Ab monomers (5 mm) for
6 h. Scale bars: 500 nm.
 2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2013, 14, 568 – 572 570
CHEMBIOCHEM
COMMUNICATIONS www.chembiochem.org
There is also an absence of Ab fibrils in the bulk solution,
strongly suggesting that the corona-coated silica NMs are
acting as a sink for Ab. In order to understand why the NM
corona binds to Ab and prevents growth of Ab fibrils, we need
to compare its surface to that of a pristine NM surface. The
pristine surface is isotropic and defined by its physico-chemical
characteristics, such as size, shape, hydrophobicity and charge.
The corona surface however is a highly anisotropic, hetero-
geneous and dynamic. It is composed of a variety of proteins,
each with different affinities for Ab monomers and higher
order Ab assemblies. If only some of the proteins contained in
the NM corona have sufficient affinity to bind Ab monomers
this will limit either the capacity of the NM to bind Ab, or the
ability of Ab to form higher order assemblies. Steric repulsion
from proteins in the corona may also play a role in preventing
addition of Ab monomers to pre-existing Ab oligomers within
the NM corona. On the basis of experiments performed at
60 8C, at which the proteins were denatured (Figure S3), how-
ever, it seems that the NM protein corona must contain pro-
teins in their native form to be effective as an inhibitor of fibril
formation. Corona proteins that have been denatured by heat
actually accelerate the formation of protein fibrils, mostly likely
due to the exposure of hydrophobic amino acid residues from
proteins that do not refold after heating. Further work will be
required to understand more fully the specific mechanism by
which fibril formation is inhibited by the NM protein corona.
In summary, we have shown that the presence of the NM
protein corona inhibits the formation of Ab fibrils for all of the
NMs investigated, whereas the same NMs accelerated the rate
of Ab fibrillation when bare. DCS and TEM data suggested that
there is a direct interaction of Ab with the proteins in the NM
corona. Ab oligomers and protofibrils are observed both within
the NM corona and in the bulk solution, but mature fibrils are
absent. The protein corona creates a shell at the surface of
NMs, regardless of their core composition or shape, reduces
access of the Ab to the NM surface and thus impacts on the
rate of Ab fibril formation. The effect is modulated by the
plasma concentration used to form the NM corona, with a NM
corona formed at 10% plasma (simulation of an in vitro milieu)
being less effective at slowing Ab fibrillation than one formed
at 100% plasma (simulation of an in vivo milieu). Several key
questions emerge from these studies in the context of nano-
particle impact on protein fibrillation, which should be ex-
plored. However, we emphasize here that such investigations
should be undertaken as a precautionary measure. No results
reported here are sufficiently mature or sufficiently close to the
in vivo conditions to suggest any particular hazard is associat-
ed with the use of NMs. Rather they constitute a desire to sys-
tematically understand the issue of nanoscale interfacial rough-
ness and the impacts of NMs on fibrillation under increasingly
realistic (biologically relevant) conditions. We note first that the
NMs studied here form a relatively small set compared to
those expected to appear increasingly in products in the
coming years. From some of these future NMs, one many
expect, significantly, various types of corona, including those
that are themselves potentially profibrillar, as for example
those containing unfolded proteins, and leading to an NF-kB
response[18,19] and this aspect should be explored. Importantly,
while for corona–nanoparticle complexes there is a reduction
in the amount of protein fibrillation, there are still significant
levels of oligomerisation of Ab on the NM corona surface and
in the bulk solution. The implications of this in terms of poten-
tial hazard are not simple therefore. Indeed, Ab oligomers are
known to be more toxic than mature fibrils, and are indeed
considered by some to be important in the genesis of Alzheim-
er’s disease.[20]
Acknowledgements
M.M. was funded through an ESF EpitopeMap RNP Exchange
grant to visit CBNI, which is gratefully acknowledged. Parts of
this work were conducted under the framework of the INSPIRE
programme, funded by the Irish Government’s Programme for Re-
search in Third Level Institutions, Cycle 4, National Development
Plan 2007-2013 (M.P.M.). Additional funding from EU FP7 Small
Collaborative project NeuroNano (NMP4-SL-2008-214547, I.L.)
and EU FP7 Large Collaborative project NAMDIATREAM (NMP4-
LA-2010-246479, F.B.) is also acknowledged. J.J.M. acknowledges
financial support from the Science Foundation Ireland Stokes Lec-
tureship. The authors acknowledge Tiina Toivonen for use of the
Electron Microscopy Laboratory Centre (Conway Institue, Universi-
ty College Dublin). The authors also acknowledge Diego Stefani
for purification of the CNT.
Keywords: fibrillation · inhibitory effect · nanomaterials ·
physicochemical properties · protein corona
[1] C. M. Dobson, Nature 2003, 426, 884.
[2] a) J. D. Sipe, Annu. Rev. Biochem. 1992, 61, 947; b) L. C. Serpell, Biochim.
Biophys. Acta Mol. Basis Dis. 2000, 1502, 16; c) J. Hardy, D. J. Selkoe, Sci-
ence 2002, 297, 353; d) A. D. Williams, E. Portelius, I. Kheterpal, J. Guo,
K. D. Cook, Y. Xu, R. Wetzel, J. Mol. Biol. 2004, 335, 833.
[3] S. B. Prusiner, Proc. Natl. Acad. Sci. USA 1998, 95, 13363.
[4] R. Khurana, C. Ionescu-Zanetti, M. Pope, J. Li, L. Nielson, M. Ramirez-
Alvarado, L. Regan, A. L. Fink, S. A. Carter, Biophys. J. 2003, 85, 1135.
[5] S. Chen, V. Berthelier, J. B. Hamilton, B. O’Nuallain, R. Wetzel, Biochem-
istry 2002, 41, 7391.
[6] J. Ferkinghoff-Borg, J. Fonslet, C. B. Andersen, S. Krishna, S. Pigolotti, H.
Yagi, Y. Goto, D. Otzen, M. H. Jensen, Phys. Rev. E 2010, 82, 010901.
[7] a) H. Naiki, Amyloid Int. J. Exp. Clin. Invest. 1977, 4, 223; b) V. J. McPar-
land, A. P. Kalverda, S. W. Homans, S. E. Radford, Nat. Struc. Biol. 2002, 9,
326.
[8] L. Fei, S. Perrett, Int. J. Mol. Sci. 2009, 10, 646.
[9] E. Hellstrand, B. Boland, D. M. Walsh, S. Linse, ACS Chem. Neurosci. 2010,
1, 13.
[10] a) R. Nelson, D. Eisenberg, Adv. Protein Chem. 2006, 73, 235; b) T. Sato, P.
Kienlen-Campard, M. Ahmed, W. Liu, H. Li, J. I. Elliott, S. Aimoto, S. N.
Constantinescu, J. N. Octave, S. O. Smith, Biochemistry 2006, 45, 5503;
c) A. T. Petkova, W. M. Yau, R. Tycko, Biochemistry 2006, 45, 498.
[11] a) C. Cabaleiro-Lago, O. Szczepankiewicz, S. Linse, Langmuir 2012, 28,
1852; b) S. Goy-Lpez, J. Jurez, M. Alatorre-Meda, E. Casals, V. F. Puntes,
P. Taboada, V. Mosquera, Langmuir 2012, 28, 9113; c) A. Hirano, H. Yoshi-
kawa, S. Matsushita, Y. Yamada, K. Shiraki, Langmuir 2012, 28, 3887;
d) C. P. Shaw, D. A. Middleton, M. Volk, R. Lvy, ACS Nano 2012, 6, 1416.
[12] M. Mahmoudi, I. Lynch, M. R. Ejtehadi, M. P. Monopoli, F. Baldelli Bom-
belli, S. Laurent, Chem. Rev. 2011, 111, 5610.
[13] a) L. Xiao, D. Zhao, W.-H. Chan, M. M. F. Choi, H.-W. Li, Biomaterials 2010,
31, 91; b) S. Auer, A. Trovato, M. Vendruscolo, PLoS Comput. Biol. 2009,
 2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2013, 14, 568 – 572 571
CHEMBIOCHEM
COMMUNICATIONS www.chembiochem.org
5, e1000458; c) M. J. Kogan, N. G. Bastus, R. Amigo, D. Grillo-Bosch, E.
Araya, A. Turiel, A. Labarta, E. Giralt, V. F. Puntes, Nano Lett. 2006, 6, 110.
[14] D. Walczyk, F. Baldelli Bombelli, M. P. Monopoli, I. Lynch, K. A. Dawson, J.
Am. Chem. Soc. 2010, 132, 5761.
[15] M. P. Monopoli, D. Walczyk, A. Campbell, G. Elia, I. Lynch, F. Baldelli Bom-
belli, K. A. Dawson, J. Am. Chem. Soc. 2011, 133, 2525.
[16] C. Cabaleiro-Lago, F. Quinlan-Pluck, I. Lynch, S. Lindman, A. M. Minogue,
E. Thulin, D. M. Walsh, K. A. Dawson, S. Linse, J. Am. Chem. Soc. 2008,
130, 15437–15443.
[17] W.-h. Wu, X. Sun, Y.-p. Yu, J. Hu, L. Zhao, Q. Liu, Y.-f. Zhao, Y.-m. Li, Bio-
chem. Biophys. Res. Commun. 2008, 373, 315–318.
[18] P. Ball, ChemPhysChem 2012, 13, 2173.
[19] Z. J. Deng, M. Liang, M. Monteiro, I. Toth, R. F. Minchin, Nat. Nanotech-
nol. 2011, 6, 39.
[20] D. M. Walsh, I. Klyubin, J. V. Fadeeva, M. J. Rowan, D. J. Selkoe, Biochem.
Soc. Trans. 2002, 30, 552.
Received: January 4, 2013
Published online on February 18, 2013
 2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2013, 14, 568 – 572 572
CHEMBIOCHEM
COMMUNICATIONS www.chembiochem.org
